La maladie de Parkinson en France (serveur d'exploration) - Corpus (PubMed)

Index « MedMesh.i » - entrée « Clinical Trials as Topic »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Clinical Protocols < Clinical Trials as Topic < Clinical Trials, Phase I as Topic  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 36.
[0-20] [0 - 20][0 - 36][20-35][20-40]
Ident.Authors (with country if any)Title
000195 (2016) Yves LévyGene and Cell Therapies: Inserm at the Heart of Biomedical Revolutions.
000305 (2015) Jeffrey Cummings ; Joseph H. Friedman ; George Garibaldi ; Martin Jones ; Wayne Macfadden ; Laura Marsh ; Philippe H. RobertApathy in Neurodegenerative Diseases: Recommendations on the Design of Clinical Trials.
000345 (2015) Marie-Laure Welter ; David Grabli ; Carine Karachi ; Nicolas Jodoin ; Sara Fernandez-Vidal ; Yohann Brun ; Soledad Navarro ; Alister Rogers ; Philippe Cornu ; Bernard Pidoux ; Jérôme Yelnik ; Emmanuel Roze ; Eric Bardinet ; Marie VidailhetPallidal activity in myoclonus dystonia correlates with motor signs.
000531 (2014) John P. Seibyl ; Andreas Kupsch ; Jan Booij ; Donald G. Grosset ; Durval C. Costa ; Robert A. Hauser ; Jacques Darcourt ; Nin Bajaj ; Zuzana Walker ; Kenneth Marek ; Ian Mckeith ; John T. O'Brien ; Klaus Tatsch ; Eduardo Tolosa ; Rudi A. Dierckx ; Igor D. GrachevIndividual-reader diagnostic performance and between-reader agreement in assessment of subjects with Parkinsonian syndrome or dementia using 123I-ioflupane injection (DaTscan) imaging.
000542 (2014) Pierre-Olivier Fernagut ; Benjamin Dehay ; Aline Maillard ; Erwan Bezard ; Paul Perez ; Anne Pavy-Le Traon ; Olivier Rascol ; Alexandra Foubert-Samier ; François Tison ; Wassilios G. MeissnerMultiple system atrophy: a prototypical synucleinopathy for disease-modifying therapeutic strategies.
000676 (2013) David Devos ; Caroline Moreau ; Kathy Dujardin ; Ioav Cabantchik ; Luc Defebvre ; Regis BordetNew pharmacological options for treating advanced Parkinson's disease.
000740 (????) Hoai-Thu Thai ; France Mentré ; Nicholas H G. Holford ; Christine Veyrat-Follet ; Emmanuelle CometsA comparison of bootstrap approaches for estimating uncertainty of parameters in linear mixed-effects models.
000760 (2013) Santiago Perez-Lloret ; María Ver Nica Rey ; Anne Pavy-Le Traon ; Olivier RascolEmerging drugs for autonomic dysfunction in Parkinson's disease.
000863 (2012) Santiago Perez-Lloret ; María Ver Nica Rey ; Estelle Dellapina ; Jean Pellaprat ; Christine Brefel-Courbon ; Olivier RascolEmerging analgesic drugs for Parkinson's disease.
000951 (????) Claire Golé ; Romain Reboul ; Pascale Pisano[Gene therapy in Parkinson disease: a promising future treatment?].
000960 (2011) Santiago Perez-Lloret ; Olivier RascolSafety of rasagiline for the treatment of Parkinson's disease.
000962 (2011) Santiago Perez-Lloret ; Santiago Perez Lloret ; María Ver Nica Rey ; Luca Ratti ; Olivier RascolPramipexole for the treatment of early Parkinson's disease.
000983 (2011) Wassilios G. Meissner ; Mark Frasier ; Thomas Gasser ; Christopher G. Goetz ; Andres Lozano ; Paola Piccini ; José A. Obeso ; Olivier Rascol ; Anthony Schapira ; Valerie Voon ; David M. Weiner ; François Tison ; Erwan BezardPriorities in Parkinson's disease research.
000A15 (2011) Patrice P. DenèfleIntroduction to gene therapy: a clinical aftermath.
000A28 (2010) Santiago Perez-Lloret ; Olivier RascolDopamine receptor agonists for the treatment of early or advanced Parkinson's disease.
000A69 (2010) David Devos ; L. Defebvre ; R. BordetDopaminergic and non-dopaminergic pharmacological hypotheses for gait disorders in Parkinson's disease.
000D07 (2008) Rotigotine: Parkinson's disease: a step backward.
000D26 (2008) Grégory Porras ; Erwan BezardPreclinical development of gene therapy for Parkinson's disease.
000E26 (2006) Rasagiline. Parkinson's disease: a simple me-too.
000E94 (2006) Stéphane ThoboisProposed dose equivalence for rapid switch between dopamine receptor agonists in Parkinson's disease: a review of the literature.
000F57 (2005) Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i -k "Clinical Trials as Topic" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i  \
                -Sk "Clinical Trials as Topic" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Clinical Trials as Topic
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024